A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.

Hugely popular weight-loss jabs like Wegovy have been making headlines for enabling people to manage diabetes and excess weight along with other benefits, scientists say. Increasingly recommended by ...

Kelly Ripa ’s decision to stop drinking came with one surprise. While asking guest cohost Andy Cohen how his Dry January is going during the latest episode of Live With Kelly and Mark, the 54-year-old ...

All these years I thought that thin people — those people — just had more willpower,” Winfrey said on her podcast.

There are several potential challengers to Novo Nordisk and Eli Lilly’s obesity drugs, and Jefferies analysts see one as ...

Scientists at the University of Virginia have uncovered how different exercise intensifies the impact of the hunger hormone ghrelin in the body.

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

It's the start of a new year, and that makes now the perfect time to load up on stocks that could boost your portfolio in ...

Oprah Winfrey has recently shared her two cents on thin people after the use of weight loss drug Ozempic.On January 21, Oprah ...

Just as quickly, investors are losing their appetite for the trade. After a disappointing trial of a new Novo Nordisk drug ...

GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...

The media queen also confessed that she was reluctant to take a GLP-1 drug because she felt it was “the easy way out.” That ...